APO Research
Talk to an analyst

APO RESEARCH · REPORT

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Analysis and Forecast 2026-2032

22 December 2025194 pages

Choose your research edition.

Industry ResearchDipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Research Report 2026124 pages · $2,950 USDIndustry Growth & TrendsGlobal Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Growth and Trends Forecast to 203295 pages · $3,450 USDMarket StructureGlobal Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032180 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Outlook and Growth Opportunities 2026199 pages · $4,250 USDMarket Analysis & ForecastGlobal Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Analysis and Forecast 2026-2032194 pages · $4,950 USD

Market perspective

The global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors include Takeda, Novartis, Merck, Eli Lilly, AstraZeneca, Mitsubishi Tanabe Pharma and Boehringer, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, also provides the sales of main regions and countries. Of the upcoming market potential for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Dipeptidyl Peptidase IV (DPP-IV) Inhibitors sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Dipeptidyl Peptidase IV (DPP-IV) Inhibitors sales, projected growth trends, production technology, application and end-user industry.

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Segment by Company

Takeda

Novartis

Merck

Eli Lilly

AstraZeneca

Mitsubishi Tanabe Pharma

Boehringer

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Segment by Type

Vildagliptin

Saxagliptin

Sitagliptin

Linagliptin

Others

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Segment by Application

Hospital Pharmacies

Online Pharmacies

Retail Pharmacies

Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Dipeptidyl Peptidase IV (DPP-IV) Inhibitors manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Dipeptidyl Peptidase IV (DPP-IV) Inhibitors sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Vildagliptin Major Manufacturers Table 3. Saxagliptin Major Manufacturers Table 4. Sitagliptin Major Manufacturers Table 5. Linagliptin Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Pharmacies Major Manufacturers Table 9. Online Pharmacies Major Manufacturers Table 10. Retail Pharmacies Major Manufacturers Table 11. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Trends Table 12. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Drivers Table 13. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Opportunities and Challenges Table 14. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Restraints Table 15. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2021-2026) & (US$ Million) Table 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2027-2032) & (US$ Million) Table 18. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2021-2026) Table 19. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2027-2032) Table 20. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k tons) Table 21. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2021-2026) & (k tons) Table 22. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2027-2032) & (k tons) Table 23. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2021-2026) Table 24. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2027-2032) Table 25. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Manufacturers (US$ Million) & (2021-2026) Table 26. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Manufacturers (2021-2026) Table 27. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Manufacturers (US$ Million) & (2021-2026) Table 28. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Manufacturers (2021-2026) Table 29. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price (US$/ton) of Manufacturers (2021-2026) Table 30. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 31. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Key Manufacturers Manufacturing Sites & Headquarters Table 32. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers, Product Type & Application Table 33. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers' Establishment Date Table 34. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 35. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 36. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 37. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 38. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 39. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2021-2026) Table 40. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2027-2032) Table 41. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type 2021 VS 2025 VS 2032 (k tons) Table 42. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (k tons) Table 43. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2027-2032) & (k tons) Table 44. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2021-2026) Table 45. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2027-2032) Table 46. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2021-2026) & (US$/ton) Table 47. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2027-2032) & (US$/ton) Table 48. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 49. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 50. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 51. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2021-2026) Table 52. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2027-2032) Table 53. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application 2021 VS 2025 VS 2032 (k tons) Table 54. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (k tons) Table 55. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2027-2032) & (k tons) Table 56. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2021-2026) Table 57. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2027-2032) Table 58. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2021-2026) & (US$/ton) Table 59. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2027-2032) & (US$/ton) Table 60. Takeda Company Information Table 61. Takeda Business Overview Table 62. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 63. Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 64. Takeda Recent Development Table 65. Novartis Company Information Table 66. Novartis Business Overview Table 67. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 68. Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 69. Novartis Recent Development Table 70. Merck Company Information Table 71. Merck Business Overview Table 72. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 73. Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 74. Merck Recent Development Table 75. Eli Lilly Company Information Table 76. Eli Lilly Business Overview Table 77. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 78. Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 79. Eli Lilly Recent Development Table 80. AstraZeneca Company Information Table 81. AstraZeneca Business Overview Table 82. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 83. AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 84. AstraZeneca Recent Development Table 85. Mitsubishi Tanabe Pharma Company Information Table 86. Mitsubishi Tanabe Pharma Business Overview Table 87. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 88. Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 89. Mitsubishi Tanabe Pharma Recent Development Table 90. Boehringer Company Information Table 91. Boehringer Business Overview Table 92. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (k tons), Revenue (US$ Million), Price (US$/ton) and Gross Margin (2021-2026) Table 93. Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio Table 94. Boehringer Recent Development Table 95. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 96. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 97. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (k tons) Table 98. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2027-2032) & (k tons) Table 99. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Type (2021-2026) & (US$/ton) Table 100. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Type (2027-2032) & (US$/ton) Table 101. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 102. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 103. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (k tons) Table 104. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2027-2032) & (k tons) Table 105. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Application (2021-2026) & (US$/ton) Table 106. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Application (2027-2032) & (US$/ton) Table 107. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 109. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 110. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 111. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (k tons) Table 112. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2027-2032) & (k tons) Table 113. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Country (2021-2026) & (US$/ton) Table 114. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Country (2027-2032) & (US$/ton) Table 115. United States Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 116. Canada Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 117. Mexico Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 118. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 119. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 120. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (k tons) Table 121. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2027-2032) & (k tons) Table 122. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Type (2021-2026) & (US$/ton) Table 123. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Type (2027-2032) & (US$/ton) Table 124. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 125. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 126. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (k tons) Table 127. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2027-2032) & (k tons) Table 128. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Application (2021-2026) & (US$/ton) Table 129. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Application (2027-2032) & (US$/ton) Table 130. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 131. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 132. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 133. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 134. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (k tons) Table 135. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2027-2032) & (k tons) Table 136. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Country (2021-2026) & (US$/ton) Table 137. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Country (2027-2032) & (US$/ton) Table 138. Germany Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 139. France Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 140. U.K. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 141. Italy Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 142. Russia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 143. Spain Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 144. Netherlands Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 145. Switzerland Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 146. Sweden Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 147. Poland Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 148. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 149. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 150. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (k tons) Table 151. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2027-2032) & (k tons) Table 152. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Type (2021-2026) & (US$/ton) Table 153. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Type (2027-2032) & (US$/ton) Table 154. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 155. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 156. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (k tons) Table 157. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2027-2032) & (k tons) Table 158. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Application (2021-2026) & (US$/ton) Table 159. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Application (2027-2032) & (US$/ton) Table 160. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 161. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 162. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (k tons) Table 163. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2027-2032) & (k tons) Table 164. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Type (2021-2026) & (US$/ton) Table 165. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Type (2027-2032) & (US$/ton) Table 166. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 167. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 168. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (k tons) Table 169. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2027-2032) & (k tons) Table 170. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Application (2021-2026) & (US$/ton) Table 171. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Application (2027-2032) & (US$/ton) Table 172. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 173. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 174. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 175. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 176. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (k tons) Table 177. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2027-2032) & (k tons) Table 178. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Country (2021-2026) & (US$/ton) Table 179. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Country (2027-2032) & (US$/ton) Table 180. Japan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 181. South Korea Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 182. India Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 183. Australia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 184. Taiwan Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 185. Southeast Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 186. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2026) & (US$ Million) Table 187. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2027-2032) & (US$ Million) Table 188. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2026) & (k tons) Table 189. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2027-2032) & (k tons) Table 190. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Type (2021-2026) & (US$/ton) Table 191. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Type (2027-2032) & (US$/ton) Table 192. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2026) & (US$ Million) Table 193. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2027-2032) & (US$ Million) Table 194. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2026) & (k tons) Table 195. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2027-2032) & (k tons) Table 196. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Application (2021-2026) & (US$/ton) Table 197. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Application (2027-2032) & (US$/ton) Table 198. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 199. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 200. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 201. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021 VS 2025 VS 2032) & (k tons) Table 202. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021-2026) & (k tons) Table 203. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2027-2032) & (k tons) Table 204. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Country (2021-2026) & (US$/ton) Table 205. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Country (2027-2032) & (US$/ton) Table 206. Brazil Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 207. Argentina Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 208. Chile Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 209. Colombia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 210. Peru Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 211. Saudi Arabia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 212. Israel Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 213. UAE Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 214. Turkey Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 215. Iran Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 216. Egypt Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Table 217. Key Raw Materials Table 218. Raw Materials Key Suppliers Table 219. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors List Table 220. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Customers List Table 221. Research Programs/Design for This Report Table 222. Authors List of This Report Table 223. Secondary Sources Table 224. Primary Sources List of Figures Figure 1. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Image Figure 2. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 4. Vildagliptin Image Figure 5. Saxagliptin Image Figure 6. Sitagliptin Image Figure 7. Linagliptin Image Figure 8. Others Image Figure 9. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Pharmacies Image Figure 12. Online Pharmacies Image Figure 13. Retail Pharmacies Image Figure 14. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (2021-2032) & (US$ Million) Figure 16. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 17. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region: 2025 Versus 2032 Figure 18. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2021-2032) Figure 19. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales (2021-2032) & (k tons) Figure 20. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region: 2021 VS 2025 VS 2032 (k tons) Figure 21. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2021-2032) Figure 22. US & Canada & Mexico Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales YoY (2021-2032) & (k tons) Figure 23. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales YoY (2021-2032) & (k tons) Figure 24. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales YoY (2021-2032) & (k tons) Figure 25. Asia (Excluding China) Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales YoY (2021-2032) & (k tons) Figure 26. South America, Middle East and Africa Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales YoY (2021-2032) & (k tons) Figure 27. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 28. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 29. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 30. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 31. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 32. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2021-2032) Figure 33. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021 VS 2025 VS 2032) & (k tons) Figure 34. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 35. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2021-2032) Figure 36. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 37. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 38. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2021-2032) Figure 39. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021 VS 2025 VS 2032) & (k tons) Figure 40. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 41. Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2021-2032) Figure 42. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Type (2021-2032) Figure 43. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Type (2021-2032) Figure 44. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Application (2021-2032) Figure 45. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Application (2021-2032) Figure 46. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Country (2021-2032) Figure 47. North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Country (2021-2032) Figure 48. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Type (2021-2032) Figure 49. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Type (2021-2032) Figure 50. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Application (2021-2032) Figure 51. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Application (2021-2032) Figure 52. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Country (2021-2032) Figure 53. Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Country (2021-2032) Figure 54. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Type (2021-2032) Figure 55. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Type (2021-2032) Figure 56. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Application (2021-2032) Figure 57. China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Application (2021-2032) Figure 58. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Type (2021-2032) Figure 59. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Type (2021-2032) Figure 60. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Application (2021-2032) Figure 61. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Application (2021-2032) Figure 62. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Country (2021-2032) Figure 63. Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Country (2021-2032) Figure 64. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Type (2021-2032) Figure 65. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Type (2021-2032) Figure 66. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Application (2021-2032) Figure 67. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Application (2021-2032) Figure 68. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Share by Country (2021-2032) Figure 69. SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Share by Country (2021-2032) Figure 70. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Value Chain Figure 71. Manufacturing Cost Structure Figure 72. Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Mode & Process Figure 73. Direct Comparison with Distribution Share Figure 74. Distributors Profiles Figure 75. Years Considered Figure 76. Research Process Figure 77. Key Executives Interviewed

Scope & coverage.

Types
  • Vildagliptin
  • Saxagliptin
  • Sitagliptin
  • Linagliptin
  • Others
Applications
  • Hospital Pharmacies
  • Online Pharmacies
  • Retail Pharmacies
Companies covered
  • Takeda
  • Novartis
  • Merck
  • Eli Lilly
  • AstraZeneca
  • Mitsubishi Tanabe Pharma
  • Boehringer

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market by Type
  3. 1.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Vildagliptin
  5. 1.2.3 Saxagliptin
  6. 1.2.4 Sitagliptin
  7. 1.2.5 Linagliptin
  8. 1.2.6 Others
  9. 1.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market by Application
  10. 1.3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital Pharmacies
  12. 1.3.3 Online Pharmacies
  13. 1.3.4 Retail Pharmacies
  14. 1.4 Assumptions and Limitations
  15. 1.5 Study Goals and Objectives
2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Dynamics
  1. 2.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Trends
  2. 2.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Drivers
  3. 2.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Opportunities and Challenges
  4. 2.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region
  3. 3.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2021-2026)
  5. 3.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Region (2027-2032)
  6. 3.2.4 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region
  9. 3.4.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2021-2026)
  11. 3.4.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Region (2027-2032)
  12. 3.4.4 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Manufacturers
  2. 4.1.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Manufacturers
  6. 4.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers, Product Type & Application
  13. 4.7 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market CR5 and HHI
  16. 4.8.2 2025 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Tier 1, Tier 2, and Tier 3
5 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market by Type
  1. 5.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type
  2. 5.1.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type
  6. 5.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2032) & (k tons)
  8. 5.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Type (2021-2032)
  9. 5.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type
6 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market by Application
  1. 6.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application
  2. 6.1.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application
  6. 6.2.1 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2032) & (k tons)
  8. 6.2.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Market Share by Application (2021-2032)
  9. 6.3 Global Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application
7 Company Profiles
  1. 7.1 Takeda
  2. 7.1.1 Takeda Company Information
  3. 7.1.2 Takeda Business Overview
  4. 7.1.3 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  6. 7.1.5 Takeda Recent Developments
  7. 7.2 Novartis
  8. 7.2.1 Novartis Company Information
  9. 7.2.2 Novartis Business Overview
  10. 7.2.3 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Novartis Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  12. 7.2.5 Novartis Recent Developments
  13. 7.3 Merck
  14. 7.3.1 Merck Company Information
  15. 7.3.2 Merck Business Overview
  16. 7.3.3 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Merck Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  18. 7.3.5 Merck Recent Developments
  19. 7.4 Eli Lilly
  20. 7.4.1 Eli Lilly Company Information
  21. 7.4.2 Eli Lilly Business Overview
  22. 7.4.3 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Eli Lilly Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  24. 7.4.5 Eli Lilly Recent Developments
  25. 7.5 AstraZeneca
  26. 7.5.1 AstraZeneca Company Information
  27. 7.5.2 AstraZeneca Business Overview
  28. 7.5.3 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 AstraZeneca Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  30. 7.5.5 AstraZeneca Recent Developments
  31. 7.6 Mitsubishi Tanabe Pharma
  32. 7.6.1 Mitsubishi Tanabe Pharma Company Information
  33. 7.6.2 Mitsubishi Tanabe Pharma Business Overview
  34. 7.6.3 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Mitsubishi Tanabe Pharma Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  36. 7.6.5 Mitsubishi Tanabe Pharma Recent Developments
  37. 7.7 Boehringer
  38. 7.7.1 Boehringer Company Information
  39. 7.7.2 Boehringer Business Overview
  40. 7.7.3 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Boehringer Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Product Portfolio
  42. 7.7.5 Boehringer Recent Developments
8 North America
  1. 8.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Type
  2. 8.1.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2032)
  3. 8.1.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2032)
  4. 8.1.3 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2021-2032)
  5. 8.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Application
  6. 8.2.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2032)
  7. 8.2.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2032)
  8. 8.2.3 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2021-2032)
  9. 8.3 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country
  10. 8.3.1 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Type
  2. 9.1.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2032)
  3. 9.1.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2032)
  4. 9.1.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2021-2032)
  5. 9.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Application
  6. 9.2.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2032)
  7. 9.2.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2032)
  8. 9.2.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2021-2032)
  9. 9.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country
  10. 9.3.1 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Type
  2. 10.1.1 China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2032)
  3. 10.1.2 China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2032)
  4. 10.1.3 China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2021-2032)
  5. 10.2 China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Application
  6. 10.2.1 China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2032)
  7. 10.2.2 China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2032)
  8. 10.2.3 China Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Type
  2. 11.1.1 Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2032)
  3. 11.1.2 Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2032)
  4. 11.1.3 Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2021-2032)
  5. 11.2 Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Application
  6. 11.2.1 Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2032)
  7. 11.2.2 Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2032)
  8. 11.2.3 Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2021-2032)
  9. 11.3 Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country
  10. 11.3.1 Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Type
  2. 12.1.1 SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Type (2021-2032)
  5. 12.2 SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Application
  6. 12.2.1 SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Application (2021-2032)
  9. 12.3 SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Market Size by Country
  10. 12.3.1 SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Value Chain Analysis
  2. 13.1.1 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Production Mode & Process
  6. 13.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Distributors
  9. 13.2.3 Dipeptidyl Peptidase IV (DPP-IV) Inhibitors Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst